Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

R&D Systems™ NMS 873
GREENER_CHOICESDP

Catalog No. 61805RD Shop All Novus Products
Change view
Click to view available options
Quantity:
5 mg
25 mg
2 product options available for selection
Product selection table with 2 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
61-805-RD 5 mg
61-802-5 25 mg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 2 options available.
2 options
This item is not returnable. View return policy
Catalog No. 61-805-RD Supplier R&D Systems™ Supplier No. 6180/5

Customers require a valid business account associated to their profile to access pricing and ordering options.

missing translation for 'validMainframeMsg'

This item is not returnable. View return policy

A Tocris product, part of R&D Systems. Potent and selective p97 ATPase (VCP) allosteric inhibitor

NMS 873 is a potent p97 ATPase (VCP) allosteric inhibitor (IC50 = 30 nM). Selective over all other AAA ATPases, HSP90 and kinases tested (IC50 >10 μM). Activates the unfolded protein response (UPR) and modulates autophagosome maturation. Exhibits antiproliferative activity in cancer cells in vitro (IC50 values are 400 and 700 nM for HCT116 and HeLa cells respectively). Reduces p97-sensitization to trypsin digestion.

Specifications

Chemical Name or Material 3-[3-(Cyclopentylthio)-5-[[[2-methyl-4'-(methylsulfonyl)[1,1'-biphenyl]-4-yl]oxy]methyl]-4H-1,2,4-triazol-4-yl]pyridine
CAS 1418013-75-8
Assay Percent Range >98%
Quantity 5 mg
Product Line Tocris
Molecular Formula C27H28N4O3S2
Formula Weight Observed MW: 520.67
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.